Dr. Jonathan De Pass is an Angel Investor. Dr. De Pass founded and also served as Board Member at Evaluate. Dr. De Pass co-owned and served as Board Member at Advera Health Analytics. He is a world-recognized leader in market intelligence and analysis for the life science sector has led the way in creating new industry standards for forecasting global drug sales and other performance metrics. Prior to founding EvaluatePharma in 1996, Dr. de Pass was a top-ranked pharmaceutical analyst in the London investment-banking arena, where his insights guided venture capital and securities investments. He earned a Masters in Management from the London Business School and a Bachelor of Medicine and a Bachelor of Surgery degree from the University of Bristol in the U.K.